Physician

Thomas Anthony Baudo, M.D.

According to 2025 Medicare claims, Thomas Baudo, M.D. (NPI: 1205881976) practices ophthalmology in the Sebastian-Vero Beach-West Vero Corridor, FL market, with the plurality of this provider's patient population coming from Indian River, FL. This provider's primary affiliated billing organization is FLORIDA EYE INSTITUTE, P.A. (NPI: 1053356337; TIN: 59-2511162) and primary practice location at 32960-5225.

Baudo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,995 traditional Medicare patients, billed 122,933 HCPCS/CPT codes, and received $6,325,498 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 2,507 prescription claims across 609 beneficiaries totaling $257,272 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 35 records totaling $836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.5M$7.1M2015 Medicare payment: $7,089,928 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $6,809,233 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $6,304,092 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $6,671,264 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,729,755 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,161,514 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,004,445 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,644,567 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,443,016 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,325,498 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,95937,739$7,089,928
20162,04934,970$6,809,233
20172,04631,875$6,304,092
20182,06033,229$6,671,264
20191,96234,061$6,729,755
20201,75729,990$6,161,514
20211,83330,136$6,004,445
20221,88430,128$5,644,567
20231,88841,785$5,443,016
20241,995122,933$6,325,498

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$129K$257K2015 Drug cost: $161,319 (USD; Tot_Drug_Cst)2016 Drug cost: $175,395 (USD; Tot_Drug_Cst)2017 Drug cost: $182,195 (USD; Tot_Drug_Cst)2018 Drug cost: $203,488 (USD; Tot_Drug_Cst)2019 Drug cost: $183,464 (USD; Tot_Drug_Cst)2020 Drug cost: $179,341 (USD; Tot_Drug_Cst)2021 Drug cost: $164,791 (USD; Tot_Drug_Cst)2022 Drug cost: $169,201 (USD; Tot_Drug_Cst)2023 Drug cost: $158,966 (USD; Tot_Drug_Cst)2024 Drug cost: $257,272 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153871,658$161,319
20163881,783$175,395
20174041,896$182,195
20184592,182$203,488
20193971,613$183,464
20203571,520$179,341
20213641,460$164,791
20223671,489$169,201
20234341,596$158,966
20246092,507$257,272

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye690946$123
92273Measurement of retinal and optic nerve function7791,055$90
92014Established patient complete exam of visual system1,7853,807$90
92134Imaging of retina1,8664,336$29
92250Photography of the retina9011,154$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine452,835$53,801
RhopressaNetarsudil Mesylate663,082$39,752
LumiganBimatoprost683,873$38,749
VyzultaLatanoprostene Bunod391,934$18,912
LatanoprostLatanoprost93761,420$14,128

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$836Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas Anthony Baudo, M.D.?

Tedicare shows public-source Medicare data for Thomas Anthony Baudo, M.D. (NPI 1205881976), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Anthony Baudo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas Anthony Baudo, M.D.?

Thomas Anthony Baudo, M.D. is linked to FLORIDA EYE INSTITUTE, P.A. (billing NPI 1053356337) in the available physician profile data.

Does Thomas Anthony Baudo, M.D. have Open Payments data?

Thomas Anthony Baudo, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.